Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

MEROPENEM

MEROPENEM

Standard Dose
500MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MEROPENEM is listed in Drugs@FDA under application 216424 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MEROPENEM Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor QILU Submission history Latest submission status date: 2026-02-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview MEROPENEM is listed in Drugs@FDA under application 216424 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MEROPENEM Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor QILU Submission history Latest submission status date: 2026-02-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.